teex procainamide

Antiarrythmic

Suppresses phase 4 depolarization in normal ventricular muscle and purkinje fibers reducing the automaticity of ectopic pacemakers

• 1. Second line for atrial and ventricular arrhythmias
• 2. Recurrent VF / VT
• 3. wide complex tachycarida

• 1. Do not use in AV block or bradycardia
• 2. Digitalis Toxicity
• 3. Preexisting QT prolongation
• 4. Torsades de Pointes
• 5. TCA Toxicity

caution in patient's with MI and renal / hepatic disfunction

• 1. Hypotension, AV block, wide QRS, bradycardia, asystole
• 2. CNS depression, hallucination, confusion, dizziness, siezures
• 3. nausea vomitting, fever

VT / VF refractory to lidocaine: 100mg over 5 minutes or 20 mg / min

• End point of medication is reached if:
• 1. suppression of arrhythmias
• 2. 17 mg / kg reached
• 3. QRS wider than 50%
• 4. Hypotension

Infuse at 1 mg / min if med suppresses VT. Reduce in renal failure

IV infusion

vial: 1gm / 10ml or 1gm / 2ml

Not recommended